Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYMR | VCEL | SWTX | ||
| Company | Kymera Therapeutics Inc | Vericel Corporation | Springworks Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 43.70 | 56.70 | 36.36 | ||
| High | 45.94 | 60.15 | 39.61 | ||
| Low | 43.28 | 56.51 | 36.24 | ||
| Last | 44.98 | 59.11 | 39.02 | ||
| Change | +1.47 | +2.40 | +2.72 | ||
| % Change | +3.38% | +4.23% | +7.49% | ||
| Volume | 559,300 | 603,400 | 1,413,100 | ||
| 20-Day Average Volume | 434,340 | 455,655 | 1,435,995 | ||
| Previous Close | 43.51 | 56.71 | 36.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.95 | 51.07 | 33.67 | ||
| 20-Day Raw Stochastic | 31.87% | 93.71% | 94.31% | ||
| 20-Day Relative Strength | 46.93% | 70.47% | 64.37% | ||
| Weighted Alpha | +64.52 | +64.27 | +30.56 | ||
| Today's Opinion | 32% Buy | 56% Buy | 8% Sell | ||
| Previous Opinion | 40% Buy | 56% Buy | 24% Sell | ||
| Last Month's Opinion | 80% Buy | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.20% since 11/15/24 | +12.63% since 11/15/24 | +7.05% since 11/15/24 | ||
| Low | 41.12 on 11/18/24 | 51.53 on 11/18/24 | 34.29 on 11/19/24 | ||
| High | 45.94 on 11/22/24 | 60.15 on 11/22/24 | 39.61 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | -7.01% since 10/22/24 | +41.31% since 10/22/24 | +30.96% since 10/22/24 | ||
| Low | 41.12 on 11/18/24 | 41.34 on 10/23/24 | 28.21 on 10/24/24 | ||
| High | 53.23 on 11/11/24 | 60.15 on 11/22/24 | 39.61 on 11/22/24 | ||
| 3-Month | |||||
| %Chg | -1.90% since 08/22/24 | +24.44% since 08/22/24 | -3.96% since 08/22/24 | ||
| Low | 41.12 on 11/18/24 | 39.12 on 10/10/24 | 28.21 on 10/24/24 | ||
| High | 53.27 on 09/26/24 | 60.15 on 11/22/24 | 43.64 on 08/26/24 | ||
| 6-Month | |||||
| %Chg | +25.99% since 05/22/24 | +17.44% since 05/22/24 | -11.86% since 05/22/24 | ||
| Low | 29.24 on 06/28/24 | 39.12 on 10/10/24 | 28.21 on 10/24/24 | ||
| High | 53.27 on 09/26/24 | 60.15 on 11/22/24 | 44.64 on 05/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,913,130 | 2,917,552 | 2,902,542 | ||
| Shares Outstanding, K | 64,765 | 49,358 | 74,386 | ||
| Annual Sales | 78,590,000 | 197,520,000 | 5,450,000 | ||
| Annual Net Income | -146,960,000 | -3,180,000 | -325,100,000 | ||
| Last Quarter Sales | 3,740,000 | 57,910,000 | 49,300,000 | ||
| Last Quarter Net Income | -62,490,000 | -900,000 | -53,530,000 | ||
| 60-Month Beta | 2.21 | 1.66 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.82 on 10/31/24 | -0.02 on 11/07/24 | -0.72 on 11/12/24 | ||
| Latest Earnings Date | 10/31/24 | 11/07/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 945.17 | 0.00 | ||